# Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients

> **NCT05056636** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Fabry Disease

## Interventions

- **DIAGNOSTIC_TEST:** Plasma α-Gal A activity; Plasma Lyso-GB3; GLA genetic sequencing.

## Key facts

- **NCT ID:** NCT05056636
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2021-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05056636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05056636, "Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05056636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*